Emmes Publications | Emmes

Search

Show only items where

Author

Type

Term

Year

Keyword

Found 10 results

Author Title Type [ Year

]

Filters: Author is Nussenblatt, RB [Clear All Filters]

2009

Sen, HN, A Sangave, K Hammel, G Levy-Clarke, and RB Nussenblatt. 2009. “Infliximab For The Treatment Of Active Scleritis”. Can J Ophthalmol 44. Can J Ophthalmol: e9-e12. http://www.ncbi.nlm.nih.gov/pubmed/19506593.

2007

Buggage, RR, G Levy-Clarke, HN Sen, R Ursea, SK Srivastava, EB Suhler, C Alternare, et al.. 2007. “A Double-Masked, Randomized Study To Investigate The Safety And Efficacy Of Daclizumab To Treat The Ocular Complications Related To Behçet's Disease”. Ocul Immunol Inflamm 15. Ocul Immunol Inflamm: 63-70. http://www.ncbi.nlm.nih.gov/pubmed/17558830.

2006

Nussenblatt, RB, J Kim, DJS Thompson, MD Davis, E Chew, FL Ferris, and RR Buggage. 2006. “Randomized Cinical Trial Of Vitamin E In The Treatment Of Uveitis-Associated Macular Edema”. Am J Ophthalmol 141. Am J Ophthalmol: 193-194. http://www.ncbi.nlm.nih.gov/pubmed/16386999.

2005

Nussenblatt, RB, JS Peterson, CS Foster, NA Rao, RF See, E Letko, and RR Buggage. 2005. “Initial Evaluation Of Subcutaneous Daclizumab Treatments For Noninfectious Uveitis: A Multicenter Noncomparative Interventional Case Series”. Ophthalmology 112. Ophthalmology: 764-770. http://www.ncbi.nlm.nih.gov/pubmed/15878055.

2004

Nussenblatt, RB, N Rao, CS Foster, HN Sen, R Ursea, Z Li, DJ Thompson, JS Peterson, RS Shames, and RR Buggage. 2004. “Uveitis Therapy: A Phase Ii Study Using Subcutaneously Administered Daclizumab”.

2003

Nussenblatt, RB, DJS Thompson, Z Li, JS Peterson, RR Robinson, RS Shames, S Nagarajan, et al.. 2003. “Humanized Anti-Interleukin-2 (Il-2) Receptor Alpha Therapy: Long-Term Results In Uveitis Patients And Preliminary Safety And Activity Data For Establishing Parameters For Subcutaneous Administration”. J Autoimmun 21. J Autoimmun: 283-293.

Nussenblatt, RB, NA Rao, CS Foster, HN Sen, S Srivastava, R Ursea, Z Li, et al.. 2003. “Subcutaneously Administered Daclizumab (Sc-Dac, Humanized Anti-Il-2 Receptor Antibody) Therapy For Uveitis”.

2000

Nussenblatt, RB, E Fortin, R Schiffman, L Risso, J Smith, P Van Veldhuisen, P Sran, et al.. 2000. “The Use Of Monoclonal Therapy In The Treatment Of Intraocular Inflammatory Disease”.

1999

Whitcup, SM, E Fortin, AS Lindblad, P Griffiths, JA Metcalf, MR Robinson, J Manischewitz, et al.. 1999. “Discontinuation Of Ant Cytomegalovirus Therapy In Patients With Hiv Infection And Cytomegalovirus Retinitis”. Jama 282. Jama: 1633-37.

Nussenblatt, RB, E Fortin, R Schiffman, L Rizzo, J Smith, P Van Veldhuisen, P Sran, et al.. 1999. “Treatment Of Noninfectious Intermediate And Posterior Uveitis With The Humanized Anti-Tac Mab: A Phase I/ii Clinical Trial”. Proceedings Of The National Academy Of Science Usa 96. Proceedings Of The National Academy Of Science Usa: 7462-66.